About Radiance Therapeutics
Radiance Therapeutics is a private company based in Tucson, Arizona, incorporated in 2018 in Delaware. It has reported $18,710,536 raised in four offerings on Form D since June 2018. Its chief executive is Laurence Marsteller.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 10, 2020 | Dec 29, 2020amended Jun 29, 2023 | $8,989,186of $10.5M target | 51 | $176K | Debt, OptionsRule 506(b) | Form D/A ↗2 earlier filings |
| Jan 9, 2019 | Jan 23, 2019amended Oct 26, 2020 | $6,186,350of $7.0M target | 60 | $103K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 20, 2018 | Aug 3, 2018amended Jan 23, 2019 | $3,525,000fully sold | 45 | $78,333 | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| May 21, 2018 | Jun 4, 2018 | $10,000fully sold | 7 | $1,429 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $18,710,536 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Radiance Therapeutics's Form D filed Jun 29, 2023.
MS
Marc Sandroff
Director
GS
G. Todd Silva
Executive officer
PK
Peng Khaw
Director
KA
Ken Abrahams
Director
LM
Laurence Marsteller
Chief Executive Officer and director
Earlier filings also listed Harry George (director, last listed Oct 2020).